BRIEF-Bayer says to invest more than 500 million euros for the manufacturing of hemophilia a products currently in development

FRANKFURT, March 11 Tue Mar 11, 2014 10:33am EDT

Related Topics

FRANKFURT, March 11 (Reuters) - Bayer AG says: * to invest more than 500 million Euros for the manufacturing of hemophilia A products currently in development Expansion of manufacturing capacities for innovative therapy options

FILED UNDER: